A detailed history of Group One Trading, L.P. transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Group One Trading, L.P. holds 1,619 shares of ADPT stock, worth $9,195. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,619
Holding current value
$9,195
% of portfolio
0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.37 - $5.12 $5,456 - $8,289
1,619 New
1,619 $8,000
Q1 2024

May 10, 2024

SELL
$2.88 - $4.8 $78,900 - $131,500
-27,396 Reduced 88.78%
3,462 $11,000
Q4 2023

Feb 14, 2024

BUY
$3.46 - $5.33 $48,000 - $73,943
13,873 Added 81.68%
30,858 $151,000
Q3 2023

Nov 09, 2023

BUY
$5.07 - $8.44 $74,265 - $123,629
14,648 Added 626.79%
16,985 $92,000
Q2 2023

Aug 09, 2023

SELL
$6.19 - $8.78 $13,252 - $18,797
-2,141 Reduced 47.81%
2,337 $15,000
Q1 2023

May 12, 2023

SELL
$7.8 - $10.11 $267,625 - $346,884
-34,311 Reduced 88.46%
4,478 $39,000
Q4 2022

Feb 09, 2023

BUY
$6.26 - $9.34 $242,819 - $362,289
38,789 New
38,789 $296,000
Q2 2022

Aug 11, 2022

SELL
$6.4 - $14.73 $85,376 - $196,498
-13,340 Reduced 79.56%
3,428 $28,000
Q1 2022

May 12, 2022

BUY
$10.12 - $28.9 $169,692 - $484,595
16,768 New
16,768 $233,000
Q3 2021

Nov 12, 2021

SELL
$30.02 - $39.87 $24,316 - $32,294
-810 Closed
0 $0
Q2 2021

Aug 10, 2021

SELL
$32.22 - $44.59 $29,674 - $41,067
-921 Reduced 53.21%
810 $33,000
Q1 2021

May 12, 2021

BUY
$37.26 - $67.74 $64,497 - $117,257
1,731 New
1,731 $70,000
Q1 2020

May 13, 2020

SELL
$16.96 - $34.16 $25,066 - $50,488
-1,478 Closed
0 $0
Q4 2019

Feb 10, 2020

BUY
$24.56 - $32.8 $36,299 - $48,478
1,478 New
1,478 $44,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $812M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.